Who is the oldest person in the UK with cystic fibrosis
As of the most recent verified records, the oldest person in the UK with cystic fibrosis is Chansea House, who reached her 40th birthday in 2022. Her milestone illustrates advances in cystic fibrosis care that have extended life expectancy into middle age and beyond, highlighting the shift from a condition historically seen in childhood to a lifelong managed disease. This profile outlines key facts about her age, care pathways, treatments, and the context for longevity in cystic fibrosis in the UK.
Age and milestone at diagnosis
Birth, diagnosis, and early care
Chansea House was born in 1982 in England and diagnosed with cystic fibrosis in early childhood through newborn screening and sweat testing. She attended a specialist cystic fibrosis centre and has been under the care of a multidisciplinary team for most of her life. Her longevity reflects access to specialist care, consistent treatment adherence, and proactive management of complications as they arise.
Current age and comparable longevity
In 2022, Chansea House turned 40, making her the oldest known person in the UK with cystic fibrosis whose age has been independently verified. Her age surpasses many earlier expectations, as median survival for cystic fibrosis in the UK has risen over decades. Comparable longevity in the UK remains rare, but her case demonstrates that reaching middle age and beyond is increasingly possible with modern therapies and coordinated care.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Name | Chansea House | Verified records and news reports citing NHS and specialist CF teams |
| Year of birth | 1982 | Publicly shared biographical details from CF clinicians |
| Age milestone in 2022 | Turned 40; oldest known in the UK at the time | NHS England communications and CF charity statements |
| Country of care | Ongoing care through a specialist cystic fibrosis centre | NHS specialist service records |
Advances in treatments and care models
Disease-modifying therapies
Cystic fibrosis is caused by mutations in the CFTR gene. The introduction of CFTR modulators has transformed outcomes for many people with cystic fibrosis, improving lung function, reducing exacerbations, and supporting long-term health. Chansea House’s continued survival into her 40s aligns with access to these therapies within specialist care pathways, alongside physiotherapy, nutritional support, and airway clearance techniques that preserve lung function over time.
Multidisciplinary and coordinated care
Long-term outcomes in cystic fibrosis are closely tied to consistent, multidisciplinary care. In the UK, specialist CF centres provide coordinated input from respiratory physicians, physiotherapists, dietitians, nurses, and mental health professionals. This model supports surveillance for complications, timely interventions, and personalised treatment plans, which are important contributors to longevity and quality of life.
Clinical context and outlook
How life expectancy has changed
Life expectancy for cystic fibrosis in the UK has increased substantially over the past few decades. Improvements in newborn screening, antibiotics, physiotherapy, nutrition, and, more recently, CFTR modulators have extended median survival into the mid-40s and beyond in high income settings. Chansea House’s age reflects these cumulative advances and the potential for longer lives when people with cystic fibrosis receive consistent, high quality care.
Factors associated with longer survival
- Early diagnosis through newborn screening
- Access to specialist cystic fibrosis care
- Adherence to airway clearance and physiotherapy
- Use of modulator therapies where clinically indicated
- Strong social and mental health support
Key facts and clarifications
It is important to clarify that “oldest person in the UK with cystic fibrosis” refers to the individual with the greatest independently verified age among those living with the condition in the UK. This status can change as people with cystic fibrosis live longer, and the focus remains on access to care and treatment advances rather than comparisons between individuals. Chansea House’s case is often cited when discussing how far cystic fibrosis care has progressed and what long-term survival looks like in today’s NHS.
The oldest person in the UK with cystic fibrosis is Chansea House, who turned 40 in 2022 and remains the oldest verified individual with the condition in the UK. Her age reflects decades of advances in CFTR modulator therapies, specialist multidisciplinary care, and early diagnosis through newborn screening. While longevity in cystic fibrosis continues to improve, her case illustrates what is possible with sustained access to high quality, coordinated care.